Overview
Hind Hamdan is a Hematologist Oncology provider in Hagerstown, Maryland. Dr. Hamdan is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Mountain Sickness, Marginal Zone Lymphoma (MZL), and Sideroblastic Anemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Maryland Oncology Hematology PA
Frederick Min is a Hematologist Oncology specialist and an Oncologist in Laurel, Maryland. Dr. Min is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. His top areas of expertise are Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Chronic Familial Neutropenia, and Agranulocytosis. Dr. Min is currently accepting new patients.
Frederick P Smith MD A Division Of RCCA
Dr. Frederick P. Smith is a medical oncologist specializing in breast cancer at Sibley Memorial Hospital and an instructor at Johns Hopkins School of Medicine and Georgetown University School of Medicine. He has a private practice in Washington, D.C. He is affiliated with Sibley Memorial Hospital and Suburban Hospital. Dr. Smith earned his medical degree from Saint Louis University School of Medicine. He completed a residency in internal medicine at Georgetown University Hospital, followed by a fellowship in oncology. Dr. Smith was named a 2012 Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly, as well as a Top MD by Consumers’ Checkbook Magazine. Prior to joining Johns Hopkins, Dr. Smith was the director of extramural oncology research at Georgetown University. In this position, he contributed over 50 articles to peer-reviewed medical journals. Dr. Smith is an integral advocate in the community for promoting access to clinical research. He has also contributed to clinical trials. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor.
Maryland Oncology Hematology PA
Jeanine Werner is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Werner is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Virilizing Ovarian Tumor. Dr. Werner is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Mountain SicknessDr. Hamdan isAdvanced. Learn about Acute Mountain Sickness.
- Breast CancerDr. Hamdan isAdvanced. Learn about Breast Cancer.
- HemochromatosisDr. Hamdan isAdvanced. Learn about Hemochromatosis.
- Marginal Zone Lymphoma (MZL)Dr. Hamdan isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Myelodysplastic Syndrome (MDS)Dr. Hamdan isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Polycythemia VeraDr. Hamdan isAdvanced. Learn about Polycythemia Vera.
- Experienced
- Adult Soft Tissue SarcomaDr. Hamdan isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Hamdan isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Hamdan isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Hamdan isExperienced. Learn about Antiphospholipid Syndrome.
- Bladder CancerDr. Hamdan isExperienced. Learn about Bladder Cancer.
- Childhood Acute Myeloid LeukemiaDr. Hamdan isExperienced. Learn about Childhood Acute Myeloid Leukemia.